US2007277826A1PendingUtilityA1
Systems and methods for modulating autonomic function
Assignee: ADVANCED CIRCULATORY SYS INCPriority: Nov 9, 1993Filed: Mar 22, 2007Published: Dec 6, 2007
Est. expiryNov 9, 2013(expired)· nominal 20-yr term from priority
Inventors:Keith G. Lurie
A61M 16/0084A61M 16/0078A61M 2230/30A61M 2016/0027A61H 31/006A61H 31/00A61H 2201/5007A61M 2230/50A61M 16/20A61M 2016/0036A61M 2230/432A61M 2230/06A61M 2016/0021A61M 16/202A61M 2230/42A61M 16/208A61M 16/0825A61M 16/024A61M 2230/208A61M 16/06A61M 2230/205A61M 16/0009A61M 16/107
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
In one embodiment, a method for modulating a person's autonomic function comprises interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event. The person is permitted to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to transiently decrease intrathoracic pressure and thereby modulate the person's autonomic function.
Claims
exact text as granted — not AI-modified1 - 22 . (canceled)
23 . A method for altering a person's intracranial pressure to thereby modulate the person's autonomic tone, the method comprising:
interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event; permitting the person to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to transiently decrease intrathoracic pressure, decrease intracranial pressure and thereby modulate the person's autonomic tone; wherein the valve system includes a pressure responsive inflow valve, and further comprising setting an actuating pressure of the valve to be in the range from about −2 cm H2O to about −30 cm H2O.
24 . A method as in claim 23 , further comprising setting the actuating pressure of the valve to be in the range from about −3 cm H2O to about −12 cm H2O for flow rates between about 30 to about 50 liters per minute.
25 . A method as in claim 23 , wherein during inhalation the valve system functions to decrease the person's heart rate and peripheral vascular tone.
26 . A method as in claim 23 , wherein during inhalation the valve system functions to increase blood flow back to the right heart of the person, thereby enhancing vital organ perfusion and function.
27 . A method as in claim 23 , wherein during inhalation the valve system functions to increase heart rate variability.
28 . A method as in claim 23 , wherein during inhalation the valve system functions to reduce the person's anxiety level.
29 . A method as in claim 23 , wherein during inhalation the valve system functions to treat shock secondary to hypovolemia, sepsis and heart failure.
30 . A method as in claim 23 , wherein during inhalation the valve system functions to treat states of hypo-perfusion that are selected from a group consisting of wound healing, stroke and diseases where blood flow is compromised, wherein at least one of the diseases comprises coronary artery disease.
31 . A method as in claim 23 , wherein during inhalation the valve system functions to improve blood flow to the muscles and brain, thereby reducing heart rate and enhancing recovery from physical exertion.
32 . A method as in claim 23 , wherein the valve system is incorporated into a facial mask or a mouthpiece, and further comprising coupling the facial mask or the mouthpiece to the person's face.
33 . A method as in claim 23 , further comprising coupling at least one physiological sensor to the patient to monitor at least one physiological parameter of the person while breathing through the valve system, and varying the actuating pressure based on the monitored physiological parameter.
34 . A method for repetitively increasing a person's sympathetic tone to prevent hypotension, the method comprising:
interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event; permitting the person to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to improve blood flow to the muscles and brain, and to increase the person's sympathetic tone to prevent hypotension; wherein the valve system includes a pressure responsive inflow valve, and further comprising setting an actuating pressure of the valve to be in the range from about −2 cm H2O to
35 . A method for repetitively increasing a person's sympathetic tone to prevent hypotension, the method comprising:
interfacing a valve system to the person's airway, the valve system being configured to decrease or prevent respiratory gas flow to the person's lungs during at least a portion of an inhalation event; permitting the person to inhale and exhale through the valve system, wherein during inhalation the valve system functions to produce a vacuum within the thorax to improve blood flow to the muscles and brain, and to increase the person's sympathetic tone to prevent hypotension; wherein the valve system includes a pressure responsive inflow valve, and further comprising setting an actuating pressure of the valve to be in the range from about −2 cm H2O to about −30 cm H2O; and measuring one or more physiological parameters before and after a period of inhalation through the valve system to thereby evaluate the patient's condition based on a change of such measured parameters.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.